| abstract |
The present invention relates to pyrimidine derivative compounds represented by general formula I or salts of such compounds. The present invention relates to a pyrimidine derivative compound represented by general formula I or a salt of such a compound, a pyrimidine derivative compound represented by general formula I as a drug, or a pharmaceutically acceptable salt of these compounds. And a pharmaceutical composition further comprising at least one of such compounds or pharmaceutically acceptable salts of these compounds and a pharmaceutically acceptable carrier, diluent or excipient, and a combination or Pharmaceutically acceptable salts of these compounds as P2Y 12 receptor antagonists as peripheral or visceral, hepatic, renal, cardiovascular, cerebrovascular, cerebrovascular diseases and thrombosis in humans or other mammals For the treatment and / or prevention of conditions associated with platelet aggregation. [Selection figure] None |